See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Maximus, Inc. (MMS) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Maximus, Inc. (MMS) - free report >>
Image: Bigstock
New Strong Sell Stocks for December 7th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
MAXIMUS, Inc. (MMS - Free Report) is a provider of business process services to government health and human services programs. The Zacks Consensus Estimate for its current year earnings has been revised 5.3% downward over the last 30 days.
International Seaways, Inc. (INSW - Free Report) is the owner and operator of a fleet of oceangoing vessels for the transportation of crude oil and petroleum products. The Zacks Consensus Estimate for its current year earnings has been revised 104.9% downward over the last 30 days.
Atkore International Group Inc. (ATKR - Free Report) is the manufacturer and distributor of electrical raceway products. The Zacks Consensus Estimate for its current year earnings has been revised 0.6% downward over the last 30 days.
Arotech Corporation is a provider of defense and security products. The Zacks Consensus Estimate for its current year earnings has been revised 15.8% downward over the last 30 days.
Abaxis, Inc. is a developer and seller of portable blood analysis systems. The Zacks Consensus Estimate for its current year earnings has been revised 5.2% downward over the last 30 days.
View the entire Zacks Rank #5 List.